Optimi Health Corp.
Optimi Health Corp.
Optimi Health is the only psychedelics pharmaceutical manufacturer in Canada with both a Controlled
Drugs and Substances Dealer’s Licence and a Drug Establishment Licence (DEL). Specializing in controlled
substances such as botanical psilocybin and MDMA, Optimi is dedicated to supplying safe, top-tier GMPgrade
products and API to researchers, drug developers, and authorized patients in markets across the
world.
Our leadership is reinforced by our state-of-the-art, GMP-compliant cultivation, formulation, and
analytical facilities, purpose-built to develop proprietary formulations that meet the highest standards of
quality and responsible sourcing. Located in Princeton, British Columbia, our two facilities total 20,000
square feet where all products are grown and manufactured in-house under strict GACP and GMP
conditions, ensuring unparalleled quality and reliability. Optimi Health is committed to being the most
trusted and compassionate supplier of safe drug candidates worldwide.
Optimi Health Corp. (OPTI)
SEDAR Information
Information d'entreprise
Capitalisation
Company Officers
Bulletins
2023-0217 - Expiration - Optimi Health Corp. 24FEB2023 Warrants (OPTI.WT)
le 22 février/February 2023
Optimi Health Corp. 24FEB2023 Warrants listed on February 25, 2021 will expire on February 24, 2023.
Settlement Terms: All trades February 22 and 23 will settle for cash next day. Trades on February 24, 2023 will be for cash same day.
The warrants will be halted at noon and delisted at market close February 24, 2023.
________________________
